Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05522426 · ClinicalTrials.gov registry record · NA
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
A NA study of Facial Atrophy and Loss of Contour, sponsored by Syntr Health Technologies.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT05522426 is a NA study of Facial Atrophy and Loss of Contour that is active but no longer recruiting, run by Syntr Health Technologies. The registered enrollment target is 50 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT05522426, a NA study of Facial Atrophy and Loss of Contour, is active but no longer recruiting, sponsored by Syntr Health Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites.
Conditions Studied
Interventions
- DEVICE SyntrFuge System
Study Locations (2)
California
- Newport Beach Site 1 - Newport
- Newport Beach Site 2 - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05522426
The ClinicalTrials.gov registry entry for NCT05522426 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syntr Health Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Atrophy and Loss of Contour appearing as the primary indexed condition, and to 1 intervention - of which SyntrFuge System is the first listed.
NCT05522426 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05522426 about?
NCT05522426 is a clinical study titled "Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting". This is an open label multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in facial aesthetics and contouring. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an inject...
What is the current status of trial NCT05522426?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-01. Estimated completion is 2025-12.
What conditions does trial NCT05522426 study?
This clinical trial studies the following conditions: Facial Atrophy and Loss of Contour.
What interventions are being tested in trial NCT05522426?
The interventions under investigation include: SyntrFuge System (DEVICE).
Who is sponsoring clinical trial NCT05522426?
This trial is sponsored by Syntr Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05522426 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.